Avantor Inc (NYSE:AVTRpA.PFD)
$ 90.81 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 50.20 PB Ratio: 2.77 GF Score: 76/100

Avantor Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 12:10PM GMT
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

All right. Good morning, everyone, to day 2 of the Morgan Stanley Healthcare Conference. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at MS.

It's my pleasure to host Avantor this morning. And on behalf of the company, we have Michael Stubblefield, CEO. Thank you for joining us, Michael.

Before we get started, just some important disclosures, please use the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So Michael, maybe just to kick things off, Avantor has seen its pressure of challenges with the COVID headwinds, the inventory destock, softer demand in pharma, semis, et cetera. But just at this stage, could you talk about how '23 has played out so far versus your initial expectations at the start of the year? And what are you sort of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot